Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Dispatch.
Press releases published on May 23, 2025

Falcon, Toll Group과 격납고 및 글로벌 비행 지원을 위한 3개년 계약 체결
두바이, 아랍에미리트공화국, May 23, 2025 (GLOBE NEWSWIRE) -- 알렉스 그룹 인베스트먼트 (Alex Group Investment)의 계열사인 Falcon이 Toll Group과 체결한 3개년 계약에 따라 향후 UAE 정부 및 방위 사업과 관련해 UAE의 격납고 서비스 및 전 세계 비행 지원 서비스를 제공할 업체로 선정되었다. 이 계약은 단거리 여행 및 정부 관련 임무에 주로 사용되는 쌍발 엔진 항공기인 Saab340의 장기 주차 …

Falcon Menandatangani Perjanjian Tiga Tahun dengan Tol Group untuk Sokongan Hangar dan Penerbangan Global
DUBAI, Emiriah Arab Bersatu, May 23, 2025 (GLOBE NEWSWIRE) -- Falcon, sebahagian daripada Alex Group Investment, telah dipilih oleh Toll Group untuk menyediakan perkhidmatan hangar di UAE dan sokongan penerbangan global di bawah perjanjian tiga tahun yang …

Falcon assina contrato de três anos com o Toll Group para serviços de hangar e suporte de voo global
DUBAI, Emirados Árabes Unidos, May 23, 2025 (GLOBE NEWSWIRE) -- A Falcon, parte do Alex Group Investment, foi selecionada pelo Toll Group para fornecer serviços de hangar nos Emirados Árabes Unidos e suporte de voo em todo o mundo em um contrato de três …

Falcon 与 Toll Group 签署有关提供机库及全球航班支持的三年协议
迪拜,阿联酋, May 23, 2025 (GLOBE NEWSWIRE) -- Alex Group Investment 旗下的 Falcon 已被 Toll Group 选中,将为该集团提供在阿联酋的机库服务和全球范围的航班支持,双方签署的三年协议涉及当地政府和国防事务。 该协议包括长期停放 Saab 340, 这是一款常用于短途飞行和政府公务的双引擎飞机。 Falcon Technic 机库占地 13,705 平方米,全天候开放,是阿联酋最大的私人飞机机库之一,可同时轻松容纳多架飞机。 这里也是 …

Falcon 與 Toll Group 簽署有關提供機庫及全球航班支援的三年協議
杜拜,阿聯酋, May 23, 2025 (GLOBE NEWSWIRE) -- Alex Group Investment 旗下的 Falcon 已被 Toll Group 選中,將為該集團提供在阿聯酋的機庫服務和全球範圍的航班支援,雙方簽署的三年協議涉及當地政府和國防事務。 該協議包括長期停放 Saab 340, 這是一款常用於短途飛行和政府公務的雙引擎飛機。 Falcon Technic 機庫佔地 13,705 平方米,全天候開放,是阿聯酋最大的私人飛機機庫之一,可同時輕鬆容納多架飛機。 這裡亦是 …

Falcon ลงนามข้อตกลงสามปีกับ Toll Group เพื่อโรงเก็บเครื่องบินและการสนับสนุนเที่ยวบินทั่วโลก
ดูไบ สหรัฐอาหรับเอมิเรตส์, May 23, 2025 (GLOBE NEWSWIRE) -- Falcon ซึ่งเป็นส่วนหนึ่งของ Alex Group Investment ได้รับเลือกจาก Toll Group …

Wix Acquires Hour One to Expand Generative AI Capabilities and Accelerate Product Innovation
NEW YORK-- Today Wix.com Ltd. (Nasdaq: WIX), the leading SaaS website builder platform globally1, announced its acquisition of Hour One, a pioneer in generative AI media creation. This acquisition marks yet another milestone in Wix’s transformation into a …

Forte Minerals Announces Private Placement of up to C$2.4 Million
“Not for distribution to United States newswire services or for dissemination in the United States.” VANCOUVER, British Columbia, May 23, 2025 (GLOBE NEWSWIRE) -- Forte Minerals Corp. (“Forte” or the “Company”) (CSE: CUAU) (OTCQB: FOMNF) (Frankfurt: 2OA), …

Allogene Therapeutics Announces Participation in Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif., May 23, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer and autoimmune disease, today …

Crinetics Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference 2025
SAN DIEGO, May 23, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), today announced that company management will participate in the Jefferies Global Healthcare Conference, taking place June 3-5, 2025 in New York, NY. Jefferies …

Bitcoin Solaris 2025 Presale Gains Momentum with Explosive Growth and Mobile Mining Breakthrough
TALLINN, Estonia, May 23, 2025 (GLOBE NEWSWIRE) -- As the crypto market enters a new phase of innovation and user empowerment, Bitcoin Solaris (BTC-S) is emerging as one of 2025’s most compelling blockchain opportunities. With its ongoing presale …

Sol-Gel Reports First Quarter 2025 Results
NESS ZIONA, Israel, May 23, 2025 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a clinical-stage dermatology company, today announced financial results for the first quarter ended March 31, 2025. Financial Results for the First Quarter Year …

Invivyd Announces Inclusion of PEMGARDA® (pemivibart) in National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology for B-Cell Lymphomas
WALTHAM, Mass., May 23, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), today announced that PEMGARDA® (pemivibart), its investigational monoclonal antibody, has been added to the National Comprehensive Cancer Network® (NCCN®) Clinical Practice …

Outlook Therapeutics® Announces Pricing of $13.0 Million Public Offering
ISELIN, N.J., May 23, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced the pricing of an …

HUTCHMED Highlights Clinical Data to be Presented at the 2025 ASCO Annual Meeting
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., May 23, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that new data from several studies of compounds discovered by HUTCHMED including savolitinib, …